Related Articles

• Insulin-like growth factor-I receptor antagonism results in increased cytotoxicity of breast cancer cells to doxorubicin and taxol
• Epidermal growth factor receptor and insulin-like growth factor-I receptor expression and function in human soft-tissue sarcoma cells.
• The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71
• Expression and synthesis of insulin-like growth factor (IGF)-I, -II and their receptors in human glioma cell lines
• Pre-activation of the p53 pathway through Nutlin-3a sensitises sarcomas to drozitumab therapy